Sun Pharma announced Q2 results today,70% rise in the Net profit at Rs.1812 Cr. from the last year Sept quarter. Company had net profit of Rs. 1064 Cr. in the same quarter a year ago.
Sun Pharma in Q2 results come up with,total revenue from the operations rose 5.29% from Rs. 8123 Cr. to Rs. 8553 Cr.
EBITDA margin 25.6% Vs 20.2%
Company is out performing even in this panic period of Covid decides the future growth in the stock price.After the company announced its results on the trading day Tuesday, the stock found rally of about 3.45% from the last closing price of Rs. 469.40 to Rs. 485.60.
Its can be predicated with the fundamentals of the company that the stock will cover the target of Rs.650 in short time.
Also read the stocks that can give 20-30% returns in the short time.